Clinical Trial Update: Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study assessing pharmacokinetics and safety of MRX-2843 in adults with relapsed/refractory advanced and/or metastatic solid tumors; the report provides …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumors

Drugs mentioned

• MRX-2843 (mrx-2843)

Snippet

Sponsor: Meryx, Inc. | Conditions: Advanced Cancer, Metastatic Cancer | Phase 1 | Status: COMPLETED